PapersFlow Research Brief
Renal and Vascular Pathologies
Research Guide
What is Renal and Vascular Pathologies?
Renal and vascular pathologies refer to diseases involving narrowing or occlusion of renal arteries, such as renal artery stenosis due to fibromuscular dysplasia or atherosclerotic renovascular disease, which impair renal function and often cause renovascular hypertension.
This field encompasses 65,285 papers on diagnosis and treatment of renal artery stenosis, renovascular hypertension, renal function assessment, stent placement, doppler ultrasonography, atherosclerotic renovascular disease, renal transplantation, oxidative stress, and angioplasty. Key methods include estimation of glomerular filtration rate (GFR) from serum creatinine using prediction equations validated in studies like the Modification of Diet in Renal Disease (MDRD) Study. Reduced estimated GFR shows a graded association with risks of death, cardiovascular events, and hospitalization in community populations.
Topic Hierarchy
Research Sub-Topics
Renal Artery Stenosis Diagnosis
This sub-topic covers Doppler ultrasound criteria, CTA/MRA accuracy, captopril renography, and invasive angiography for renovascular hypertension detection. Researchers validate hemodynamic thresholds predicting blood pressure response.
Fibromuscular Dysplasia Renovascular
This sub-topic examines medial fibroplasia patterns, genetic associations, and percutaneous angioplasty outcomes without stenting. Researchers study multifocal disease progression and hypertension cure rates.
Atherosclerotic Renovascular Disease
This sub-topic addresses medical optimization vs. stenting trials, ischemic nephropathy progression, and cardiovascular risk stratification. Researchers analyze ASTRAL/CORAL trial implications for conservative management.
Renovascular Hypertension Pathophysiology
This sub-topic investigates activation of renin-angiotensin-aldosterone system, sodium retention, and pressure-natriuresis reset in unilateral/bilateral stenosis. Researchers study renal baroreceptor mechanisms and compensatory hypertrophy.
Renal Stent Placement Outcomes
This sub-topic evaluates restenosis rates, renal function preservation, and procedure complications stratified by lesion characteristics. Researchers conduct meta-analyses comparing bare-metal vs. drug-eluting stents.
Why It Matters
Renal and vascular pathologies contribute to chronic kidney disease (CKD), which independently increases risks of death, cardiovascular events, and hospitalization, as demonstrated in a study of over 1 million adults where reduced GFR correlated with higher event rates (Go et al., 2004). Guidelines for managing peripheral arterial disease, including renal artery stenosis, recommend revascularization strategies like angioplasty and stent placement for patients with hemodynamically significant lesions (Hirsch et al., 2006). A multicentre study showed catheter-based renal sympathetic denervation safely reduced blood pressure by 10/8 mmHg in 45 patients with resistant hypertension, offering a targeted intervention for renovascular hypertension (Krum et al., 2009). Coronary-artery calcification, prevalent in young adults with end-stage renal disease on dialysis, underscores vascular complications linked to renal failure (Goodman et al., 2000).
Reading Guide
Where to Start
"A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation" by Levey et al. (1999), because it provides a foundational, highly cited tool for assessing renal function central to vascular pathologies.
Key Papers Explained
Levey et al. (1999) established the MDRD equation for GFR estimation, which Go et al. (2004) applied to demonstrate graded risks of death and cardiovascular events from reduced GFR. Levey et al. (2005) then defined CKD classification building on these metrics, while Hirsch et al. (2006) extended guidelines to renal artery management including stenosis interventions. Goodman et al. (2000) linked end-stage renal disease to vascular calcification, and Krum et al. (2009) tested denervation for hypertension control.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current frontiers emphasize refining revascularization techniques like angioplasty and stents for renal artery stenosis, informed by Hirsch et al. (2006) guidelines and Krum et al. (2009) denervation results. Experimental hypertension models from Goldblatt et al. (1934) continue to underpin pathophysiology studies. No recent preprints available.
Papers at a Glance
Frequently Asked Questions
What is the most accurate method to estimate glomerular filtration rate from serum creatinine?
A prediction equation from the Modification of Diet in Renal Disease Study provides a more accurate estimate of GFR than measured creatinine clearance or other common equations (Levey et al., 1999). This equation was developed and validated in a study group of patients with chronic renal disease. It accounts for factors like age, sex, and race to improve precision.
How does reduced GFR associate with clinical outcomes?
Reduced estimated GFR shows an independent, graded association with risks of death, cardiovascular events, and hospitalization in large community-based populations (Go et al., 2004). This highlights the clinical importance of chronic renal insufficiency across GFR stages. Even mild reductions increase event rates significantly.
What defines and classifies chronic kidney disease?
Chronic kidney disease is defined and classified by a position statement from Kidney Disease: Improving Global Outcomes (KDIGO), based on GFR categories and markers of kidney damage (Levey et al., 2005). This framework standardizes diagnosis globally. It guides staging from G1 to G5 based on GFR levels.
What are management guidelines for renal artery disease?
ACC/AHA 2005 guidelines cover management of peripheral arterial disease including renal, recommending diagnostic imaging like doppler ultrasonography and revascularization for significant stenosis (Hirsch et al., 2006). Stent placement and angioplasty are addressed for atherosclerotic renovascular disease. Risk factor modification is emphasized alongside interventions.
What is renal sympathetic denervation used for?
Catheter-based renal sympathetic denervation treats resistant hypertension, with a multicentre study confirming its safety and proof-of-principle in reducing office blood pressure (Krum et al., 2009). The procedure targets renal artery nerves via catheter ablation. It showed sustained effects without major adverse events in the cohort.
How common is coronary calcification in end-stage renal disease?
Coronary-artery calcification is common and progressive in young adults with end-stage renal disease undergoing dialysis, detected via electron-beam computed tomography (Goodman et al., 2000). Scores increased markedly over 12 months in patients aged 13-30. This indicates early vascular pathology in renal failure.
Open Research Questions
- ? How can renal sympathetic denervation efficacy be optimized for broader resistant hypertension populations beyond proof-of-principle cohorts?
- ? What mechanisms link renal artery stenosis severity to persistent hypertension elevation, as initiated in early experimental models?
- ? How does coronary-artery calcification progression in young dialysis patients inform preventive strategies for renal-vascular comorbidities?
- ? What refined GFR prediction equations improve accuracy across diverse populations beyond the MDRD study group?
- ? How do revascularization outcomes like stent placement vary in atherosclerotic versus fibromuscular dysplasia-related renal artery stenosis?
Recent Trends
The field maintains 65,285 works with focus on renal artery stenosis treatments like stent placement and angioplasty, as per cluster description.
Highly cited works from 1999-2017 dominate, including MDRD GFR equation (14,997 citations) and CKD risk associations (11,173 citations), indicating sustained reliance on established diagnostics over new developments.
No recent preprints or news in last 12 months.
Research Renal and Vascular Pathologies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Renal and Vascular Pathologies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers